Product Information
ESCITALOPRAM 5 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0416 per EA under NDC 69097084715. Its NADAC has been published 96 times since Dec 4, 2024.
FDA first approved this application on Sep 11, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Cipla USA Inc.NDC
69097084715
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ESCITALOPRAM OXALATEApproval Type
Generic (ANDA)
FDA Application
ANDA078604FDA Approved
9/11/2012
TE Code
AB
On Market Since
6/16/2016
Pharmacological Classes
Price Statistics
The NADAC for ESCITALOPRAM 5 MG TABLET has been published 96 times since Dec 4, 2024, and over the history we have for it it has risen 26.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0416 per EA |
|---|---|
| All-time high | $0.0474 (Jul 16, 2025) |
| All-time low | $0.0328 (Dec 4, 2024) |
| 52-week high | $0.0439 |
| 52-week low | $0.0412 |
| Median price | $0.0421 |
| Average price | $0.0426 |
| Largest weekly change | +13.8% (Dec 18, 2024) |
| Weeks tracked | 96 |
| Tracking since | Dec 4, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Escitalopram market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ESCITALOPRAM 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM 5 MG TABLET, manufactured by Cipla USA Inc., is $0.0416 per EA (NDC 69097084715), effective Sep 30, 2026.
How has the price of ESCITALOPRAM 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ESCITALOPRAM 5 MG TABLET has risen 26.9%. It has been tracked across 96 weekly CMS publications since Dec 4, 2024.
What are the highest and lowest recorded NADAC prices for ESCITALOPRAM 5 MG TABLET?
Since Dec 4, 2024, the NADAC for ESCITALOPRAM 5 MG TABLET has ranged from a low of $0.0328 (Dec 4, 2024) to a high of $0.0474 (Jul 16, 2025), with a median of $0.0421 per EA.
Are there cheaper alternatives to ESCITALOPRAM 5 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ESCITALOPRAM 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ESCITALOPRAM 5 MG TABLET?
ESCITALOPRAM 5 MG TABLET (NDC 69097084715) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.